Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

10.1186/s12885-015-1764-1

Saved in:
Bibliographic Details
Main Authors: Glynne-Jones, R, Hava, N, Goh, V, Bosompem, S, Bridgewater, J, Chau, I, Gaya, A, Wasan, H, Moran, B, Melcher, L, MacDonald, A, Osborne, M, Beare, S, Jitlal, M, Lopes, A, Hall, M, West, N, Quirke, P, Wong, W.-L, Harrison, M, and for the Bacchus investigato
Other Authors: SURGERY
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/181427
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-181427
record_format dspace
spelling sg-nus-scholar.10635-1814272024-04-25T02:38:08Z Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum Glynne-Jones, R Hava, N Goh, V Bosompem, S Bridgewater, J Chau, I Gaya, A Wasan, H Moran, B Melcher, L MacDonald, A Osborne, M Beare, S Jitlal, M Lopes, A Hall, M West, N Quirke, P Wong, W.-L Harrison, M and for the Bacchus investigato SURGERY bevacizumab fluorouracil folinic acid irinotecan oxaliplatin angiogenesis inhibitor antineoplastic agent bevacizumab advanced cancer Article cancer adjuvant therapy cancer combination chemotherapy cancer control cancer grading cancer prognosis cancer regression cancer size cancer staging colostomy computer assisted emission tomography continuous infusion controlled study disease free survival drug efficacy drug monitoring drug safety drug tolerability feasibility study follow up high risk patient histopathology human human tissue multicenter study multiple cycle treatment nuclear magnetic resonance imaging open study outcome assessment overall survival patient compliance phase 2 clinical trial preoperative treatment progression free survival prospective study randomized controlled trial rectum cancer rectum surgery total mesorectal excision treatment response abdominal surgery adjuvant chemotherapy aged clinical trial combination drug therapy female male neoadjuvant therapy prognosis Rectal Neoplasms treatment outcome Aged Angiogenesis Inhibitors Antineoplastic Agents Bevacizumab Chemotherapy, Adjuvant Digestive System Surgical Procedures Drug Therapy, Combination Female Humans Male Neoadjuvant Therapy Prognosis Prospective Studies Rectal Neoplasms Treatment Outcome 10.1186/s12885-015-1764-1 BMC Cancer 15 1 764 2020-10-27T10:53:29Z 2020-10-27T10:53:29Z 2015 Article Glynne-Jones, R, Hava, N, Goh, V, Bosompem, S, Bridgewater, J, Chau, I, Gaya, A, Wasan, H, Moran, B, Melcher, L, MacDonald, A, Osborne, M, Beare, S, Jitlal, M, Lopes, A, Hall, M, West, N, Quirke, P, Wong, W.-L, Harrison, M, and for the Bacchus investigato (2015). Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. BMC Cancer 15 (1) : 764. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-015-1764-1 14712407 https://scholarbank.nus.edu.sg/handle/10635/181427 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic bevacizumab
fluorouracil
folinic acid
irinotecan
oxaliplatin
angiogenesis inhibitor
antineoplastic agent
bevacizumab
advanced cancer
Article
cancer adjuvant therapy
cancer combination chemotherapy
cancer control
cancer grading
cancer prognosis
cancer regression
cancer size
cancer staging
colostomy
computer assisted emission tomography
continuous infusion
controlled study
disease free survival
drug efficacy
drug monitoring
drug safety
drug tolerability
feasibility study
follow up
high risk patient
histopathology
human
human tissue
multicenter study
multiple cycle treatment
nuclear magnetic resonance imaging
open study
outcome assessment
overall survival
patient compliance
phase 2 clinical trial
preoperative treatment
progression free survival
prospective study
randomized controlled trial
rectum cancer
rectum surgery
total mesorectal excision
treatment response
abdominal surgery
adjuvant chemotherapy
aged
clinical trial
combination drug therapy
female
male
neoadjuvant therapy
prognosis
Rectal Neoplasms
treatment outcome
Aged
Angiogenesis Inhibitors
Antineoplastic Agents
Bevacizumab
Chemotherapy, Adjuvant
Digestive System Surgical Procedures
Drug Therapy, Combination
Female
Humans
Male
Neoadjuvant Therapy
Prognosis
Prospective Studies
Rectal Neoplasms
Treatment Outcome
spellingShingle bevacizumab
fluorouracil
folinic acid
irinotecan
oxaliplatin
angiogenesis inhibitor
antineoplastic agent
bevacizumab
advanced cancer
Article
cancer adjuvant therapy
cancer combination chemotherapy
cancer control
cancer grading
cancer prognosis
cancer regression
cancer size
cancer staging
colostomy
computer assisted emission tomography
continuous infusion
controlled study
disease free survival
drug efficacy
drug monitoring
drug safety
drug tolerability
feasibility study
follow up
high risk patient
histopathology
human
human tissue
multicenter study
multiple cycle treatment
nuclear magnetic resonance imaging
open study
outcome assessment
overall survival
patient compliance
phase 2 clinical trial
preoperative treatment
progression free survival
prospective study
randomized controlled trial
rectum cancer
rectum surgery
total mesorectal excision
treatment response
abdominal surgery
adjuvant chemotherapy
aged
clinical trial
combination drug therapy
female
male
neoadjuvant therapy
prognosis
Rectal Neoplasms
treatment outcome
Aged
Angiogenesis Inhibitors
Antineoplastic Agents
Bevacizumab
Chemotherapy, Adjuvant
Digestive System Surgical Procedures
Drug Therapy, Combination
Female
Humans
Male
Neoadjuvant Therapy
Prognosis
Prospective Studies
Rectal Neoplasms
Treatment Outcome
Glynne-Jones, R
Hava, N
Goh, V
Bosompem, S
Bridgewater, J
Chau, I
Gaya, A
Wasan, H
Moran, B
Melcher, L
MacDonald, A
Osborne, M
Beare, S
Jitlal, M
Lopes, A
Hall, M
West, N
Quirke, P
Wong, W.-L
Harrison, M
and for the Bacchus investigato
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
description 10.1186/s12885-015-1764-1
author2 SURGERY
author_facet SURGERY
Glynne-Jones, R
Hava, N
Goh, V
Bosompem, S
Bridgewater, J
Chau, I
Gaya, A
Wasan, H
Moran, B
Melcher, L
MacDonald, A
Osborne, M
Beare, S
Jitlal, M
Lopes, A
Hall, M
West, N
Quirke, P
Wong, W.-L
Harrison, M
and for the Bacchus investigato
format Article
author Glynne-Jones, R
Hava, N
Goh, V
Bosompem, S
Bridgewater, J
Chau, I
Gaya, A
Wasan, H
Moran, B
Melcher, L
MacDonald, A
Osborne, M
Beare, S
Jitlal, M
Lopes, A
Hall, M
West, N
Quirke, P
Wong, W.-L
Harrison, M
and for the Bacchus investigato
author_sort Glynne-Jones, R
title Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_short Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_full Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_fullStr Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_full_unstemmed Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_sort bevacizumab and combination chemotherapy in rectal cancer until surgery (bacchus): a phase ii, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/181427
_version_ 1800914636922421248